EIR GlaxoSmithKline dba Human Genome Sciences Apr 2016

Jonathan Chapman FDA, Chaltu Wakijra FDA$595.00 - Available Now

FDA investigators audited the GlaxoSmithKline dba Human Genome Sciences - Rockville, MD, United States facility and issued inspectional observation (via FDA 483) on 11 Apr 2016.

Product details

  • Category:
  • Inspection end: 11 Apr 2016
  • Location: Rockville, United States
  • FEI: 3003782237
Add To Cart